We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLB icon
4551
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
$9K ﹤0.01%
216
-16,054
-99% -$650K
XMTR icon
4552
Xometry
XMTR
$5.34B
$9K ﹤0.01%
609
-5,009
-89% -$132K
XPL icon
4553
Solitario Resources
XPL
$73.6M
$9K ﹤0.01%
13,228
+3,071
+30% +$2.09K
ZVSA
4554
DELISTED
ZyVersa Therapeutics
ZVSA
$9K ﹤0.01%
+13
New +$9.72K
GTI
4555
DELISTED
Graphjet Technology
GTI
$9K ﹤0.01%
14
– –
SER icon
4556
Serina Therapeutics
SER
$42.7M
$9K ﹤0.01%
385
-92
-19% -$2.11K
QXO
4557
QXO Inc
QXO
$16.1B
$9K ﹤0.01%
364
+76
+26% +$1.96K
CLYM
4558
Climb Bio
CLYM
$846M
$9K ﹤0.01%
3,262
+2,620
+408% +$9K
ACCS
4559
ACCESS Newswire
ACCS
$20M
$9K ﹤0.01%
417
+57
+16% +$1.44K
NAGE
4560
Niagen Bioscience
NAGE
$241M
$9K ﹤0.01%
5,350
-13,489
-72% -$24K
VIVS
4561
VivoSim Labs
VIVS
$1.15M
$9K ﹤0.01%
339
+227
+203% +$5.42K
SPRB
4562
Spruce Biosciences
SPRB
$135M
$9K ﹤0.01%
52
-94
-64% -$17.5K
FFNW
4563
DELISTED
First Financial Northwest, Inc
FFNW
$9K ﹤0.01%
737
+169
+30% +$2.48K
ATXI
4564
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$9K ﹤0.01%
+107
New +$9.89K
SNAX
4565
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$9K ﹤0.01%
1,249
+286
+30% +$2.92K
AE
4566
DELISTED
Adams Resources & Energy Inc
AE
$9K ﹤0.01%
223
-120
-35% -$5.9K
SCWX
4567
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$9K ﹤0.01%
1,109
-2,054
-65% -$15.8K
KACL
4568
DELISTED
Kairous Acquisition Corp. Limited Ordinary Shares
KACL
$9K ﹤0.01%
860
-47
-5% -$498
WHLM
4569
DELISTED
Wilhelmina International, Inc
WHLM
$9K ﹤0.01%
2,078
-1,096
-35% -$4.67K
AUMN
4570
DELISTED
Golden Minerals Company
AUMN
$9K ﹤0.01%
1,902
+602
+46% +$3.83K
GLLIU
4571
DELISTED
Globalink Investment Inc. Unit
GLLIU
$9K ﹤0.01%
800
– –
LLAP
4572
DELISTED
Terran Orbital Corporation
LLAP
$9K ﹤0.01%
4,693
-2,691
-36% -$5.19K
TUP
4573
DELISTED
Tupperware Brands Corporation
TUP
$9K ﹤0.01%
3,685
+76
+2% +$280
CVIIU
4574
DELISTED
Churchill Capital Corp VII Units
CVIIU
$9K ﹤0.01%
921
-8
-0.9% -$81
CALB
4575
DELISTED
California BanCorp Common Stock
CALB
$9K ﹤0.01%
482
+446
+1,239% +$10.5K
181 182
183
184 185

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.